Viatris Inc (VTRS)

13.28
+0.07(+0.53%)
Pre Market
13.28
0.00(0.00%)
- Real-time Data
  • Volume:
    7,554,514
  • Bid/Ask:
    13.30/13.50
  • Day's Range:
    13.15 - 13.43

VTRS Overview

Prev. Close
13.28
Day's Range
13.15 - 13.43
Revenue
11.95B
Open
13.22
52 wk Range
12.95 - 19.24
EPS
-0.6
Volume
7,554,514
Market Cap
16.03B
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
10,805,183
P/E Ratio
N/A
Beta
1.52
1-Year Change
-14.1%
Shares Outstanding
1,207,082,624
Next Earnings Date
May 11, 2021
What is your sentiment on Viatris Inc?
or
Market is currently closed. Voting is open during market hours.

Viatris Inc News

Viatris Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellSellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong BuyStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell

Viatris Inc Company Profile

Viatris Inc Company Profile

Employees
45000

Viatris Inc., formerly Upjohn Inc., is a healthcare company. It is a scientific, manufacturing and distribution company that is specialized in delivering medicines to patients in over 165 countries and territories. It provides access to medicines, advance sustainable operations, develop solutions and leverage it's specializatiin to connect people to products and services through it's Global Healthcare Gateway. It's portfolio comprises of more than 1,400 molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, global brands, complex generic and branded medicines, portfolio of biosimilars and a variety of over-the-counter consumer products. It produces medicines for patients across a broad range of therapeutic areas, spanning both noncommunicable and infectious diseases, which include cardiovascular, oncology, immunology, women’s healthcare, diabetes and metabolism, gastroenterology, respiratory and allergy and dermatology.

Read More
  • 13+today
    0
    • seems like new low is coming
      0
      • run, you fools (c)Gendalf
        0
        • wt i should do in this stock
          0
          • put it in your *******
            0
          • 0
          • Hey, donot worry. Next Qtr will be better. price will shoot up to $17
            1
        • sell and hold
          1
          • dont sell. hold it. dont give your shares cheap away to melvin. :p
            1
            • Wow.. I’ve been buying more share every time it drops but it doesn’t stop.. Melvin hedge fund is shorting this stock.. I guess they need to make the money money they lost from gme.. we need to short squeeze this stock like gme and amc..
              2
              • i just own a few shares which i got for free at spin-off day. if its under 11 i will buy a few more.
                0
              • Melvin = koks@ker
                0
            • what is going on? it drops and drops day after day
              0
              • Calls
                1
                • Buy
                  0
                  • Can’t win with this stock. When market goes up this stock goes down and when market goes down this stock goes down also. Worst investment I’ve made.. worst management.. stay away from this garbage
                    1
                    • James are still double or triple in the long like you were saying Feb 3? Or is it garbage garbage now
                      0
                    • I was long but I’m buying a property soon so I want/ need this stock to go up now! This may go lower as price target got reduced to $18. If you’re not in a hurry, this is definitely doing to go up double to several folds... insiders are buying but hedge fund is shorting heavily... if this can get a short squeeze like gme, amc it’ll be nice! Good luck!
                      0
                  • 18 analysts average outlook target $19.50 with high at $27. They declared a 3% dividend yesterday and new CEO wants to under promise and over deliver so he forecasted very conservative 2021 near term. This stock is set to do very well.
                    1
                    • You’re so funny. That outlook was same since they merged. I’ve had the stock since it was mylan but the management refuse to sell it to teva at $ 100 plus per share and now it’s a piece of garbage.
                      1
                    • You’re so funny. That outlook was same since they merged. I’ve had the stock since it was mylan but the management refuse to sell it to teva at $ 100 plus per share and now it’s a piece of garbage.
                      1
                  • reason for big fall today?
                    0
                    • anyone can explain?
                      0
                    • market...fomo
                      0
                    • Worst company to invest in short term. Management is not investor friendly.
                      1
                  • we should pop soon above 19.15
                    1
                    • long term = hedge funds still shorting VTRS.
                      1
                      • is this stock good for the long term? any thoughts? thx
                        0
                        • Long term it’ll double to triple for sure but may take time.. if you have money you don’t need right away, this stock will definitely be worth to hold.. with dividend they’re planning to give, it’s a great long term investment
                          1
                        • James Pa do they give dividends ?
                          0
                        • good long term hold, dividends coming
                          0
                      • lets visit 26 area. bought 17 area.
                        0
                        • Worst company to invest in short term.. while other hedge fund stock like GameStop gets a short squeeze, this stock is too small to be recognized.. management should’ve sold this to Teva when it was offered more than 100 but selfish and incompetent management passed on it and now it’s struggle.. while other stocks are making all time high.. this company is being neglected.
                          1
                          • 15.20 is next target
                            4
                            • why do you think it will fall so much?
                              0
                          • any notes why the fall?
                            0
                            • CEO is saying flat growth, tough 2021 with layoffs and facility closing.
                              0
                            • Worst company to invest in short term.
                              0
                          • got me 124 shares of this when the split from PFE a few days ago, better than the webull free sign up shares lol.
                            2
                            • idk but this stock is having a very hard time moving higher.
                              0
                          • managment must consider of  buying back shares
                            0
                            • why VTRS is so hard to move high??
                              1
                              • It is interesting how myopic people are. Everyone seems to have forgotten and bypassed the fact that Mylan is the most efficient and competitive flu vaccine manufacturer. This new merger has shaped an excellent new hybrid big pharma company with hidden synergies and unlimited upside. Viatris is the best and cheapest stock in sector and the fact that it is still selling below 20 $ is unbelievable..!
                                0
                                • Maybe time to sell phizer and plow into viatris??
                                  0
                              • This is so undervalued it hurts.. Fair price is from 23 to 26 USD without any premium. Great company great buying opportunity, great investment case, huge upside and practically zero downside.
                                0
                                Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.